Table 2 Percentage of candidate modification sites being identified
ac4C | m1A | m5C | m6A | m7G | Ψ | |
|---|---|---|---|---|---|---|
HepAD38 | 93.75% | 85.25% | 73.33% | 88.89% | 86.71% | 100.00% |
MT-4 | 87.88% | 86.89% | 76.47% | 82.14% | 81.07% | 86.21% |
HTLV-1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ac4C | m1A | m5C | m6A | m7G | Ψ | |
|---|---|---|---|---|---|---|
HepAD38 | 93.75% | 85.25% | 73.33% | 88.89% | 86.71% | 100.00% |
MT-4 | 87.88% | 86.89% | 76.47% | 82.14% | 81.07% | 86.21% |
HTLV-1 | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |